The impact of current opioid agonist therapy on hepatitis C virus treatment initiation among people who use drugs from the direct-acting antiviral (DAA) era: A population-based study
2021 | Clinical Infectious Diseases | Available online | Lay Summary

Prescription opioid treatment for non-cancer pain and initiation of injection drug use: Large retrospective cohort study
2021 | BMJ | Available online | Lay Summary

HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men
2020 | Liver International | In Press | Lay Summary

Drug related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada
2020 | International Journal of Drug Policy | In Press

A computable phenotype model for classification of men who have sex with men within a large linked database of laboratory, surveillance, and administrative healthcare records
2020 | Frontiers in Digital Health | In Press

Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis: Informing optimal integration of health services
2020 | International Journal of Infectious Diseases | Available Online

Concurrent hepatitis C and B virus and HIV infections are associated with higher mortality risk illustrating the impact of the syndemics on health outcomes
2020 | Open Forum Infectious Diseases | In Press

Real world effectiveness of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection: A population-based cohort study
2020 | Open Forum Infectious Diseases | Available Online

Comparing direct acting antivirals for hepatitis C using observational data - why and how?
2020 | Pharamacology Research and Perspectives | In Press

The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk
2020 | Journal of Viral Hepatitis | Available Online

Using population-level integrated health data to monitor and assess patients’ progression across care and treatment continuums
2019 | BC Medical Journal | Available Online

The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals
2019 | Liver International | Available Online

What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada
2019 | International Journal of Drug Policy | In Press

Sustained virologic response from interferon-based hepatitis C treatments associated with reduced extrahepatic manifestations risk
2019 | Journal of Hepatology | In Press

Effectiveness of ledipasvir/sofosbuvir and sofosbuvir/velpatatsvir in people who inject drugs and/or those in opioid agonist therapy
2018 | Hepatitis Communications | Available Online

Contextualizing Canada's hepatitis C virus epidemic
2018 | Canadian Liver Journal | Available Online

Applying core theory and spatial analysis to identify HCV infection 'core areas' in British Columbia, Canada
2018 | Journal of Viral Hepatitis | Available Online

Effect of opioid substitution therapy (OST) and psychotherapy on HIV risk among HCV infected individuals
2018 | Clinical Epidemiology | Available Online

Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk
2018 | Journal of Viral Hepatitis | Available Online

Syndemic characterization of HCV, HBV, and HIV co-infections in a large population based cohort study
2018 | E Clinical Medicine | Available Online

Real-world effectiveness of sofosbuvir-based regimens for hepatitis C treatment among people who inject drugs and/or those in opioid substitution therapy in Canada
2018 | Hepatology Communications | In Press

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy on a large population based cohort
2018 | Journal of Hepatology | Available Online  | Lay Summary

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
2018 | World Journal of Gastroenterology | Available Online | Lay Summary

Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets
2018 | International Journal of Drug Policy | Available Online

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international comparison
2018 | Journal of Viral Hepatitis | Available Online

The contribution of alcohol-use to decompensated cirrhosis among people with hepatitis C: An international study
2017 | Journal of Hepatology | Available Online

A syndemic approach to assess the effect of substance use and social disparities’ on the evolution of HIV/HCV infections in British Columbia 
2017 | PLOS ONE | Available Online | Lay Summary

Hepatitis C cross-genotype immunity and implications for vaccine development
2017 | Scientific Report | Available Online

Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development
2017 | Journal of Hepatology | Available Online | Lay Summary

Incidence, risk factors, and prevention of hepatitis C reinfection: A population-based cohort study
2017 | The Lancet Gastroenterology & Hepatology | Available Online

Assessing hepatitis C burden and treatment effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and characteristics of linked and unlinked participants
2016 | PLOS ONE | Available Online

Twin epidemics of new and prevalent hepatitis C infections in Canada: The BC Hepatitis Testers Cohort
2016 | BMC Infectious Diseases | Available Online

The population level cascade of care for hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
2016 | Ebiomedicine | Available Online

Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada
2016 | Journal of Hepatology | Available Online

Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of Hepatitis C: The BC Hepatitis Testers Cohort
2016 | Journal of Viral Hepatology | Available Online

Shift in disparities in Hepatitis C treatment form interferon to DAA: A population-based cohort study.
2016 | Journal of Viral Hepatology | Available Online